Definiens AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Definiens AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12360
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Definiens AG (Definiens), a subsidiary of AstraZeneca Plc, is a healthcare technology company that offers image analysis and data mining solutions. The company offers products such as tissue studio, developer, image miner, server, architect and viewer, among others. Its services include consulting and planning services, image analysis solution services, integration and deployment services and image analysis processing services. The company delivers its services in the area of clinical studies through clinical drug development, translational research and tissue diagnostics development. It has operations in Germany and the US. Definiens is headquartered in Munich, Germany.

Definiens AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Definiens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Definiens AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Definiens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Definiens AG, Medical Devices Deals, 2012 to YTD 2018 8
Definiens AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Definiens AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Definiens Raises USD20.3 Million in Venture Financing Round 10
Definiens Raises US$13 Million In Venture Financing 11
Acquisition 12
MedImmune Acquires Definiens for USD150 Million 12
Definiens AG – Key Competitors 13
Definiens AG – Key Employees 14
Definiens AG – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Jul 25, 2018: Definiens strengthens digital data and science strategy by appointing Mr. Markus Schunk as chief operating office 16
Jul 24, 2017: Definiens Forearms Organization for Strategic Expansion 17
Other Significant Developments 18
Oct 03, 2018: Definiens showcases pharma solutions for immuno-oncology profiling 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Definiens AG, Pharmaceuticals & Healthcare, Key Facts 2
Definiens AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Definiens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Definiens AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Definiens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Definiens AG, Medical Devices Deals, 2012 to YTD 2018 8
Definiens AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Definiens Raises USD20.3 Million in Venture Financing Round 10
Definiens Raises US$13 Million In Venture Financing 11
MedImmune Acquires Definiens for USD150 Million 12
Definiens AG, Key Competitors 13
Definiens AG, Key Employees 14
Definiens AG, Subsidiaries 15

List of Figures
Definiens AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Definiens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Definiens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Definiens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Definiens AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Definiens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Definiens AG, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Definiens AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Camping World Holdings, Inc. (CWH):企業の財務・戦略的SWOT分析
    Camping World Holdings, Inc. (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • The Magstim Co Ltd:企業の戦略的SWOT分析
    The Magstim Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • OnKure Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OnKure Inc (OnKure) is a drug developer that discovers and develops epigenetic therapies for the treatment of cancer. The company offers production of specific histone deacetylases inhibitors. Its lead product candidate ONK102 significantly reduces the growth rate of tumors in hematological …
  • Family Dollar Stores, Inc.:企業の戦略・SWOT・財務情報
    Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Family Dollar Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Neogen Corp (NEOG):企業の財務・戦略的SWOT分析
    Neogen Corp (NEOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Coherex Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Coherex Medical Inc (Coherex), formerly Proximare, Inc is a subsidiary of Johnson & Johnson is a medical device company that designs, develops and markets catheter-based technologies for the treatment of certain structural heart defects. The company provides treatment of cardiovascular disea …
  • Bank of the West:企業の戦略・SWOT・財務情報
    Bank of the West - Strategy, SWOT and Corporate Finance Report Summary Bank of the West - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Aeon Delight Co Ltd:企業の戦略・SWOT・財務情報
    Aeon Delight Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Aeon Delight Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Quantum Corp (QTM):企業の財務・戦略的SWOT分析
    Summary Quantum Corp (Quantum) is a technology company that offers intelligent solutions for capturing, sharing and preserving digital assets over the data lifecycle. The company provides products such as stornext scale-out storage, Q-cloud archive, quantum archives, scalar , LTO Tape Drives, DXi de …
  • Advint, LLC:企業の戦略・SWOT・財務情報
    Advint, LLC - Strategy, SWOT and Corporate Finance Report Summary Advint, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Genesis Care Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Genesis Care Pty Ltd (Genesis Care) is a healthcare service provider. The company provides radiation oncology, cardiology and sleep treatment services. It offers radiotherapy, intensity modulated radiotherapy, volumetric arc therapy, stereotactic radiotherapy and radiosurgery, low dose rate …
  • GE Healthcare LLC-医療機器分野:企業M&A・提携分析
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Median Technologies SA (ALMDT):医療機器:M&Aディール及び事業提携情報
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • Herantis Pharma Plc (HRTIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …
  • Continental Grain Co:企業の戦略的SWOT分析
    Continental Grain Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Koch Enterprises, Inc.:企業の戦略的SWOT分析
    Koch Enterprises, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CS Energy Ltd:発電所・企業SWOT分析
    CS Energy Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • FBD Holdings Plc (EG7):企業の財務・戦略的SWOT分析
    FBD Holdings Plc (EG7) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Repligen Corp (RGEN):企業の財務・戦略的SWOT分析
    Summary Repligen Corp (Repligen) is a bioprocessing life science company that develops and commercializes consumable products for manufacturing biological drugs. The company's products include Protein A affinity resins, Protein A ligands, ELISA kits, alternating tangential flow system, OPUS pre pack …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆